Companies / IPD

IMPEDIMED LIMITED

ASX:IPDHealth Care Equipment & Services
3.66B shares on issueASX (delayed) · as of 28 July 2026$0.004price · delayed$14.6Mmarket cap · indicative
D
Dilution grade

Share count grew 81% in 24 months; runway 2–4 quarters; 4 cash raises in 24 months

Cash runway2.8 quarters of funding
Share-count growth (24m)81.0%
Raise cadence (24m)4 cash raises
Options & rights overhang149.8% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

IMPEDIMED LIMITED's ordinary share count grew 81.0% between November 2024 and July 2026, to 3.66B shares. The company completed four capital raises in that period for disclosed proceeds totalling A$30.6M, most recently a Placement and SPP that raised A$15.3M in April 2026. Options and other potential securities could convert into 5.49B new shares, equal to 149.8% of the current share count, with 0% in the money at present and the nearest expiry in March 2027. At the June 2026 quarter the company reported A$13.8M in cash, equivalent to 2.8 quarters of cover at the reported run rate. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
149.8%
Max option dilution
0.0%
ITM option dilution
2
Raises · last 12 months
2.8 qtrs
Cash cover · 2–4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 3.66B per ASX (delayed) (28 July 2026).
2.37B2.84B3.32BDec 24Sept 25July 26Cash raise · 29 Apr 2026Cash raise · 29 Apr 2026Cash raise · 24 Apr 2025Cash raise · 24 Apr 2025

Cash runway

2.8 qtrs
Two to four quarters of funding at the recent spend rate.
$13.8M available cash at quarter ended 30 June 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 30 June 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
20 July 20263H · cancellationIPD : ORDINARY FULLY PAID3.66BAppendix 3H
3 July 20262A · quoted issueIPD : ORDINARY FULLY PAID3.66BAppendix 2A
3 July 20263H · cancellationIPD : ORDINARY FULLY PAID3.66BAppendix 3H
26 June 20263G · unquotedIPD : ORDINARY FULLY PAID3.66BAppendix 3G
16 June 20262A · quoted issueIPD : ORDINARY FULLY PAID3.66BAppendix 2A
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

4 cash raises in the last 24 months · 2 in the last 12 months

$15.3M
Placement and SPP
29 Apr 2026 COMPLETE
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

149.8%
Total overhang · of current shares
0.0%
In the money · at current price
5.49B
Potential new shares
Mar 2027
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
3 July 2026Ms Janelle DelaneyOther595k——3Y notice
3 July 2026Ms Christine Emmanuel-DonnellyOther866k20.0M—3Y notice
3 July 2026Fiona BonesOther595k——3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

27 July 2026Investor Presentation
27 July 2026$PQuarterly Activities Report and Appendix 4C - Jun-2026 Qtr
22 July 2026Notification of Q4 FY26 Quarterly Results Investor Webinar
20 July 2026Notification of cessation of securities - IPD
3 July 2026Change of Director's Interest Notice - Mr Andrew Grant
3 July 2026Change of Director's Interest Notice - Ms Emmanuel-Donnelly
3 July 2026Change of Director's Interest Notice - Ms Janelle Delaney
3 July 2026Change of Director's Interest Notice - Ms Fiona Bones
3 July 2026Change of Director's Interest Notice - Mr Erik Anderson
3 July 2026Application for quotation of securities - IPD
3 July 2026Notification of cessation of securities - IPD
3 July 2026Ceasing to be a substantial shareholder from AEF
26 June 2026Notification regarding unquoted securities - IPD
26 June 2026Update on Options and Holding Statements
18 June 2026Change in substantial holding
18 June 2026Change in substantial shareholding from AEF
17 June 2026Change in substantial holding
17 June 2026Change in Substantial Shareholding from AEF
16 June 2026Change of Director's Interest Notice - Mr Andew Grant
16 June 2026Change of Director's Interest Notice - Ms Emmanuel-Donnelly

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.